vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and MITEK SYSTEMS INC (MITK). Click either name above to swap in a different company.

Amarin Corp plc is the larger business by last-quarter revenue ($45.1M vs $44.2M, roughly 1.0× MITEK SYSTEMS INC). MITEK SYSTEMS INC runs the higher net margin — 6.3% vs -23.3%, a 29.5% gap on every dollar of revenue. On growth, MITEK SYSTEMS INC posted the faster year-over-year revenue change (18.8% vs 7.0%). Over the past eight quarters, MITEK SYSTEMS INC's revenue compounded faster (-2.9% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Mitek Systems, Inc. is a software company that specializes in digital identity verification and mobile image processing using artificial intelligence. The company's software is used for depositing checks and opening bank accounts via mobile devices. It also verifies identity documents such as passports, ID cards, and driver's licenses by analyzing a selfie of an individual holding their ID, comparing their face to the photo on the document.

AMRN vs MITK — Head-to-Head

Bigger by revenue
AMRN
AMRN
1.0× larger
AMRN
$45.1M
$44.2M
MITK
Growing faster (revenue YoY)
MITK
MITK
+11.8% gap
MITK
18.8%
7.0%
AMRN
Higher net margin
MITK
MITK
29.5% more per $
MITK
6.3%
-23.3%
AMRN
Faster 2-yr revenue CAGR
MITK
MITK
Annualised
MITK
-2.9%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
AMRN
AMRN
MITK
MITK
Revenue
$45.1M
$44.2M
Net Profit
$-10.5M
$2.8M
Gross Margin
Operating Margin
35.5%
12.3%
Net Margin
-23.3%
6.3%
Revenue YoY
7.0%
18.8%
Net Profit YoY
33.0%
160.1%
EPS (diluted)
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
MITK
MITK
Q1 26
$45.1M
Q4 25
$49.2M
$44.2M
Q3 25
$49.7M
$44.8M
Q2 25
$72.7M
$45.7M
Q1 25
$42.0M
$51.9M
Q4 24
$62.3M
$37.3M
Q3 24
$42.3M
$43.2M
Q2 24
$67.5M
$45.0M
Net Profit
AMRN
AMRN
MITK
MITK
Q1 26
$-10.5M
Q4 25
$-1.2M
$2.8M
Q3 25
$-7.7M
$1.9M
Q2 25
$-14.1M
$2.4M
Q1 25
$-15.7M
$9.2M
Q4 24
$-48.6M
$-4.6M
Q3 24
$-25.1M
$8.6M
Q2 24
$1.5M
$216.0K
Gross Margin
AMRN
AMRN
MITK
MITK
Q1 26
Q4 25
47.1%
Q3 25
44.7%
Q2 25
69.2%
Q1 25
59.8%
Q4 24
-15.4%
Q3 24
38.5%
Q2 24
63.4%
Operating Margin
AMRN
AMRN
MITK
MITK
Q1 26
35.5%
Q4 25
-12.9%
12.3%
Q3 25
-22.4%
10.5%
Q2 25
-22.0%
8.3%
Q1 25
-39.9%
21.9%
Q4 24
-84.3%
-8.3%
Q3 24
-59.5%
17.8%
Q2 24
-0.8%
1.6%
Net Margin
AMRN
AMRN
MITK
MITK
Q1 26
-23.3%
Q4 25
-2.5%
6.3%
Q3 25
-15.6%
4.2%
Q2 25
-19.4%
5.2%
Q1 25
-37.4%
17.6%
Q4 24
-78.0%
-12.4%
Q3 24
-59.4%
19.8%
Q2 24
2.3%
0.5%
EPS (diluted)
AMRN
AMRN
MITK
MITK
Q1 26
Q4 25
$0.00
$0.06
Q3 25
$-0.02
$0.04
Q2 25
$-0.03
$0.05
Q1 25
$-0.04
$0.20
Q4 24
$-0.12
$-0.10
Q3 24
$-0.06
$0.19
Q2 24
$0.00
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
MITK
MITK
Cash + ST InvestmentsLiquidity on hand
$307.8M
$190.1M
Total DebtLower is stronger
$4.8M
Stockholders' EquityBook value
$233.7M
Total Assets
$645.8M
$446.5M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
MITK
MITK
Q1 26
$307.8M
Q4 25
$302.6M
$190.1M
Q3 25
$286.6M
$193.0M
Q2 25
$298.7M
$167.1M
Q1 25
$281.8M
$136.2M
Q4 24
$294.2M
$121.2M
Q3 24
$305.7M
$130.3M
Q2 24
$306.7M
$123.1M
Total Debt
AMRN
AMRN
MITK
MITK
Q1 26
Q4 25
$4.8M
Q3 25
$4.3M
Q2 25
Q1 25
Q4 24
Q3 24
$2.7M
Q2 24
Stockholders' Equity
AMRN
AMRN
MITK
MITK
Q1 26
Q4 25
$459.3M
$233.7M
Q3 25
$458.9M
$240.3M
Q2 25
$464.9M
$237.6M
Q1 25
$473.7M
$220.2M
Q4 24
$486.2M
$200.9M
Q3 24
$531.4M
$214.8M
Q2 24
$551.9M
$209.6M
Total Assets
AMRN
AMRN
MITK
MITK
Q1 26
$645.8M
Q4 25
$670.8M
$446.5M
Q3 25
$659.8M
$459.1M
Q2 25
$670.1M
$446.7M
Q1 25
$655.7M
$425.3M
Q4 24
$685.3M
$396.0M
Q3 24
$750.6M
$413.8M
Q2 24
$799.9M
$409.2M
Debt / Equity
AMRN
AMRN
MITK
MITK
Q1 26
Q4 25
0.02×
Q3 25
0.02×
Q2 25
Q1 25
Q4 24
Q3 24
0.01×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
MITK
MITK
Operating Cash FlowLast quarter
$8.0M
Free Cash FlowOCF − Capex
$6.6M
FCF MarginFCF / Revenue
14.9%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
2.89×
TTM Free Cash FlowTrailing 4 quarters
$60.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
MITK
MITK
Q1 26
Q4 25
$15.3M
$8.0M
Q3 25
$-12.7M
$19.5M
Q2 25
$16.6M
$21.6M
Q1 25
$-12.5M
$13.7M
Q4 24
$-13.3M
$565.0K
Q3 24
$-2.4M
$21.1M
Q2 24
$-2.7M
$13.0M
Free Cash Flow
AMRN
AMRN
MITK
MITK
Q1 26
Q4 25
$6.6M
Q3 25
$19.2M
Q2 25
$21.2M
Q1 25
$13.5M
Q4 24
$230.0K
Q3 24
$20.8M
Q2 24
$12.6M
FCF Margin
AMRN
AMRN
MITK
MITK
Q1 26
Q4 25
14.9%
Q3 25
42.9%
Q2 25
46.5%
Q1 25
26.0%
Q4 24
0.6%
Q3 24
48.2%
Q2 24
27.9%
Capex Intensity
AMRN
AMRN
MITK
MITK
Q1 26
Q4 25
3.2%
Q3 25
0.6%
Q2 25
0.7%
Q1 25
0.4%
Q4 24
0.9%
Q3 24
0.7%
Q2 24
1.0%
Cash Conversion
AMRN
AMRN
MITK
MITK
Q1 26
Q4 25
2.89×
Q3 25
10.46×
Q2 25
9.00×
Q1 25
1.50×
Q4 24
Q3 24
2.46×
Q2 24
-1.81×
60.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

MITK
MITK

Fraud And Identity Solutions$25.5M58%
License$13.9M31%
Fraud And Identity Solutions Software License And Support$3.9M9%
Professional Services And Other$1.2M3%

Related Comparisons